$AMMJ
American Cannabis Company, Inc. Stock $ammj

$ammj Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000190359624000418 Filed on July 15, 2024

Income Statement

Concept	2024 Q3	2024 Q1	2023 Q1
Revenue		$255.7K	$712.4K
YoY Change		-64.1%	14.93%
Cost Of Revenue		$150.0K	$435.9K
YoY Change		-65.58%	-3.63%
Gross Profit		$105.7K	$276.5K
YoY Change		-61.78%	65.03%
Gross Profit Margin		41.33%	38.81%
Selling, General & Admin		$234.5K	$708.1K
YoY Change		-66.89%	4.68%
% of Gross Profit		221.85%	256.1%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$71.55K	$61.27K
YoY Change		16.78%	63.48%
% of Gross Profit		67.7%	22.16%
Operating Expenses		$234.5K	$717.2K
YoY Change		-67.31%	6.03%
Operating Profit		-$128.8K	-$440.7K
YoY Change		-70.78%	-13.4%
Interest Expense		$7.479K	-$31.63K
YoY Change		-123.65%	16.63%
% of Operating Profit
Other Income/Expense, Net		-$3.761K	-$22.28K
YoY Change		-83.12%	-260.78%
Pretax Income		-$132.6K	-$463.0K
YoY Change		-71.37%	-11.33%
Income Tax
% Of Pretax Income
Net Earnings		-$132.6K	-$463.0K
YoY Change		-71.37%	-11.33%
Net Earnings / Revenue		-51.83%	-64.99%
Basic Earnings Per Share		$0.00	$0.00
Diluted Earnings Per Share		$0.00	-$0.01
COMMON SHARES
Basic Shares Outstanding	185.8M shares	85.73M shares	85.73M shares
Diluted Shares Outstanding		85.73M shares	85.73M shares

Balance Sheet

Concept	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$10.05K	$66.09K
YoY Change	-84.79%	-98.47%
Cash & Equivalents	$10.05K	$56.50K
Short-Term Investments		$9.600K
Other Short-Term Assets	$16.88K	$66.19K
YoY Change	-74.5%	-95.37%
Inventory	$669.9K	$373.7K
Prepaid Expenses
Receivables	$120.7K	$354.8K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$817.6K	$860.8K
YoY Change	-5.02%	-86.4%
LONG-TERM ASSETS
Property, Plant & Equipment	$403.6K	$451.8K
YoY Change	-10.68%	7.88%
Goodwill		$1.332M
YoY Change
Intangibles	$758.0K	$1.177M
YoY Change	-35.59%
Long-Term Investments
YoY Change
Other Assets	$6.000K	$6.000K
YoY Change	0.0%	0.0%
Total Long-Term Assets	$1.811M	$3.548M
YoY Change	-48.96%	13.0%
TOTAL ASSETS
Total Short-Term Assets	$817.6K	$860.8K
Total Long-Term Assets	$1.811M	$3.548M
Total Assets	$2.628M	$4.409M
YoY Change	-40.38%	-53.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.070M	$793.8K
YoY Change	34.82%	101.7%
Accrued Expenses	$142.7K	$65.14K
YoY Change	119.05%	-63.5%
Deferred Revenue
YoY Change
Short-Term Debt	$300.0K	$550.0K
YoY Change	-45.45%	0.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.154M	$2.186M
YoY Change	-1.45%	-69.1%
LONG-TERM LIABILITIES
Long-Term Debt	$385.7K	$336.6K
YoY Change	14.58%	-38.8%
Other Long-Term Liabilities	$219.8K	$405.5K
YoY Change	-45.8%	260.44%
Total Long-Term Liabilities	$605.4K	$742.1K
YoY Change	-18.42%	12.02%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.154M	$2.186M
Total Long-Term Liabilities	$605.4K	$742.1K
Total Liabilities	$2.759M	$2.928M
YoY Change	-5.75%	-62.15%
SHAREHOLDERS EQUITY
Retained Earnings	-$13.87M	-$10.54M
YoY Change	31.58%
Common Stock	$1.714K	$922.00
YoY Change	85.9%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$131.0K	$1.481M
YoY Change
Total Liabilities & Shareholders Equity	$2.628M	$4.409M
YoY Change	-40.38%	-53.45%

Cashflow Statement

Concept	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	-$132.6K	-$463.0K
YoY Change	-71.37%	-11.33%
Depreciation, Depletion And Amortization	$71.55K	$61.27K
YoY Change	16.78%	63.48%
Cash From Operating Activities	-$11.29K	-$208.6K
YoY Change	-94.59%	-105.85%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$39.09K
YoY Change	-100.0%	-573.82%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities		-$39.09K
YoY Change		373.84%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$249.00	$186.6K
YoY Change	-99.87%	101.83%
NET CHANGE
Cash From Operating Activities	-$11.29K	-$208.6K
Cash From Investing Activities		-$39.09K
Cash From Financing Activities	$249.00	$186.6K
Net Change In Cash	-$11.04K	-$61.05K
YoY Change	-81.92%	-101.67%
FREE CASH FLOW
Cash From Operating Activities	-$11.29K	-$208.6K
Capital Expenditures	$0.00	$39.09K
Free Cash Flow	-$11.29K	-$247.7K
YoY Change	-95.44%	-106.93%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	13740961	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-13873676	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2628487	usd
CY2024Q1	ammj	Consulting And Advisory Revenues ConsultingAndAdvisoryRevenues	8329	usd
CY2024Q1	ammj	Equipment Supplies Revenues EquipmentSuppliesRevenues	17601	usd
CY2024Q1	ammj	Cannabis Products CannabisProducts	229891	usd
CY2024Q1	us-gaap	Revenues Revenues	255720	usd
CY2024Q1	ammj	Cost Of Equipment Supplies CostOfEquipmentSupplies	17262	usd
CY2024Q1	ammj	Cost Of Cannabis Product CostOfCannabisProduct	132764	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	150026	usd
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000945617
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q1	ammj	Cost Of Consulting And Advisory CostOfConsultingAndAdvisory		usd
CY2024Q1	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness		usd
CY2023Q1	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness		usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2024Q1	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation		usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2024Q1	us-gaap	Property Plant And Equipment Disposals PropertyPlantAndEquipmentDisposals		usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2024Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2023Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2024Q1	us-gaap	Stock Issued1 StockIssued1		usd
CY2023Q1	us-gaap	Stock Issued1 StockIssued1		usd
CY2024Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
CY2024Q1	ammj	Additional Expenses Incurred AdditionalExpensesIncurred		usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant		shares
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount		usd
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	000-26108
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	AMERICAN CANNABIS COMPANY, INC.
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	90-1116625
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	1004 Tejon Street
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Colorado Springs
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CO
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	80903
CY2024Q1	dei	City Area Code CityAreaCode	303
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	974-4770
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	185800915	shares
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10045	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	21085	usd
CY2024Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	120730	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	234330	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	669926	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	586206	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	16878	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	58757	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	817579	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	900378	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	403567	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	410344	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	973112	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1037909	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	428229	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	474472	usd
CY2024Q1	us-gaap	Deposit Assets DepositAssets	6000	usd
CY2023Q4	us-gaap	Deposit Assets DepositAssets	6000	usd
CY2024Q1	us-gaap	Other Assets OtherAssets	1407341	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	1518381	usd
CY2024Q1	us-gaap	Assets Assets	2628487	usd
CY2023Q4	us-gaap	Assets Assets	2829083	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1070181	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1010698	usd
CY2024Q1	ammj	Advances From Clients AdvancesFromClients	49492	usd
CY2023Q4	ammj	Advances From Clients AdvancesFromClients	162414	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	506383	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	467495	usd
CY2024Q1	ammj	Stock Payable StockPayable	17021	usd
CY2023Q4	ammj	Stock Payable StockPayable	17021	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	208464	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	199891	usd
CY2024Q1	us-gaap	Litigation Reserve Current LitigationReserveCurrent	2500	usd
CY2023Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	10000	usd
CY2024Q1	us-gaap	Notes Payable Current NotesPayableCurrent	300000	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	300000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	2154051	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2167519	usd
CY2024Q1	us-gaap	Notes Payable To Bank Noncurrent NotesPayableToBankNoncurrent	385682	usd
CY2023Q4	us-gaap	Notes Payable To Bank Noncurrent NotesPayableToBankNoncurrent	385433	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	219765	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	274581	usd
CY2024Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	605447	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	660014	usd
CY2024Q1	us-gaap	Liabilities Liabilities	2759498	usd
CY2023Q4	us-gaap	Liabilities Liabilities	2827533	usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	185800915	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	185800915	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	171402938	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	171402938	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	1714	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	1714	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	13740961	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-13741125	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-131001	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1550	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2829083	usd
CY2023Q1	ammj	Consulting And Advisory Revenues ConsultingAndAdvisoryRevenues	160815	usd
CY2023Q1	ammj	Equipment Supplies Revenues EquipmentSuppliesRevenues	363549	usd
CY2023Q1	ammj	Cannabis Products CannabisProducts	188021	usd
CY2023Q1	us-gaap	Revenues Revenues	712385	usd
CY2023Q1	ammj	Cost Of Consulting And Advisory CostOfConsultingAndAdvisory	45000	usd
CY2023Q1	ammj	Cost Of Equipment Supplies CostOfEquipmentSupplies	217567	usd
CY2023Q1	ammj	Cost Of Cannabis Product CostOfCannabisProduct	173309	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	435876	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	105694	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	276509	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	232134	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	652690	usd
CY2024Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2350	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	64535	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	234483	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	717225	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-128789	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-440716	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	7479	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	31634	usd
CY2024Q1	us-gaap	Other Income OtherIncome	3718	usd
CY2023Q1	us-gaap	Other Income OtherIncome	9350	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3761	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-22284	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-132551	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-463000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-132551	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-522175	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	85727938	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	85727938	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	85727938	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	85727938	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1869622	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1869622	usd
CY2023Q1	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	74342	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-522175	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	1480964	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	1480964	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1550	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1550	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-132551	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-131001	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-131001	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-132551	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-463000	usd
CY2024Q1	us-gaap	Depreciation Depreciation	71554	usd
CY2023Q1	us-gaap	Depreciation Depreciation	61271	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-113600	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-114311	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	83720	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	20765	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-41879	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-7743	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-46243	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-22912	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	59483	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	114636	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	112922	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	84760	usd
CY2024Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	38888	usd
CY2023Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	124498	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-7500	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-62500	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-46243	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-22912	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11289	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-208565	usd
CY2023Q1	us-gaap	Property Plant And Equipment Disposals PropertyPlantAndEquipmentDisposals	39092	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-39092	usd
CY2024Q1	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	249	usd
CY2023Q1	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	186610	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	249	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	186610	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-11040	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-61048	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21085	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	117547	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10045	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	56497	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84C_eus-gaap--UseOfEstimates_zg4NKqHXtmlk" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_860_zt9eaW2fTpkg">Use of Estimates in Financial Reporting</span></i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of unaudited consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the amount of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the condensed consolidated financial statements during the periods presented. Actual results could differ from these estimates. Estimates and assumptions are reviewed periodically, and the effects of revisions are reflected in the consolidated financial statements in the period in which they are deemed to be necessary. Significant estimates made in the accompanying consolidated financial statements include but are not limited to following those related to revenue recognition, allowance for doubtful accounts and unbilled services, lives and recoverability of equipment and other long-lived assets, the allocation of the asset purchase price, contingencies, and litigation. The Company is subject to uncertainties, such as the impact of future events, economic, environmental, and political factors, and changes in the business climate; therefore, actual results may differ from those estimates. When no estimate in a given range is deemed to be better than any other when estimating contingent liabilities, the low end of the range is accrued. Accordingly, the accounting estimates used in the preparation of the Company's consolidated financial statements will change as new events occur, as more experience is acquired, as additional information is obtained, and as the Company's operating environment changes. Changes in estimates are made when circumstances warrant. Such changes and refinements in estimation methodologies are reflected in reported results of operations; if material, the effects of changes in estimates are disclosed in the notes to the consolidated financial statements.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	4071	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	4071	usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2024Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84D_eus-gaap--ConcentrationRiskCreditRisk_zJ9Cnvf3RX56" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_862_z8JVS2gOVGl4">Significant Clients and Customers</span></i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three customers accounted for <span id="xdx_905_ecustom--RevenueRemainingPerformanceObligationsPercentage_iI_dp_c20240331_zXE2EJ3KMOue" title="Revenues percentage">43.4</span>% of the company's total revenues during the three months ended March 31, 2024.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three customers accounted for <span id="xdx_90F_ecustom--RevenueRemainingPerformanceObligationsPercentage_iI_dp_c20230331_zEpQX0Z2MM63" title="Revenues percentage">42.5</span>% of the company's total revenues during the three months ended March 31, 2023.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	ammj	Revenue Remaining Performance Obligations Percentage RevenueRemainingPerformanceObligationsPercentage	0.434	pure
CY2023Q1	ammj	Revenue Remaining Performance Obligations Percentage RevenueRemainingPerformanceObligationsPercentage	0.425	pure
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Method FiniteLivedIntangibleAssetsAmortizationMethod	Intangible assets are amortized on a straight-line basis over their estimated useful life. Licenses are assigned a life of 15 years, and tradenames are assigned a life of 5 years.
CY2024Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	60115	usd
CY2023Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	46333	usd
CY2024Q1	us-gaap	Revenue Recognition Sales Returns Reserve For Sales Returns RevenueRecognitionSalesReturnsReserveForSalesReturns	0	usd
CY2023Q1	us-gaap	Revenue Recognition Sales Returns Reserve For Sales Returns RevenueRecognitionSalesReturnsReserveForSalesReturns	0	usd
CY2024Q1	us-gaap	Revenue Recognition Sales Of Services RevenueRecognitionSalesOfServices	<p id="xdx_84F_eus-gaap--RevenueRecognitionSalesOfServices_zcev4NlhsDe3" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86C_zmwecwr3zDed">Consulting Services</span></i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We also generate revenues from professional services consulting agreements. These arrangements are generally entered: (1) on an hourly basis for a fixed fee or (2) on a contingent fee basis. Generally, we require a complete or partial prepayment or retainer prior to performing services. We utilize and rely upon the proportional performance method for hourly-based fixed-fee service contracts, which recognize revenue as services are completed. Under this method, in order to determine the amount of revenue to be recognized, we calculate the amount of completed work in comparison to the total services to be provided under the arrangement or deliverable. We segregate upon entry into a contract any advances or retainers received from clients for fixed fee hourly services into a separate “Advances from Clients account and only recognize revenues as we incur and charge billable hours, and then deposit the funds earned into our operating account. Because our hourly fees for services are fixed and determinable and are only earned and recognized as revenue upon actual performance, we are of the opinion that such arrangements are not an indicator of a vendor or customer-based significant financing that would materially change the amount of revenue we recognize under the contract or would otherwise contain a significant financing component under FASB ASC Topic 606.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Occasionally, our fixed-fee hourly engagements are recognized under the completed performance method. Some fixed fee arrangements are for the completion of a final deliverable or act which is significant to the arrangement. These engagements do not generally exceed a one-year term. If the performance is for a final deliverable or act, we recognize revenue under the completed performance method, in which revenue is recognized once the final act or deliverable is performed or delivered for a fixed fee. Revenue recognition is affected by a number of factors that change the estimated amount of work required to complete the deliverable, such as changes in scope, timing, awaiting notification of license award from the local government, and the level of client involvement. Losses, if any, on fixed-fee engagements are recognized in the period in which the loss first becomes probable and reasonably estimable. FASB ASC Topic 606 provides a practical expedient to disregard the effects of a financing component if the period between payment and performance is one year or less. As our fixed fee hourly engagements do not exceed one year, no significant customer-based financing is implicated under FASB ASC Topic 606. During the three months ended March 31, 2024, and 2023, we incurred no losses from fixed fee engagements that terminated prior to completion. We believe that if an engagement terminates prior to completion, we can recover the costs incurred related to the services provided.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We primarily enter into arrangements for which fixed and determinable revenues are contingent and agreed upon, achieving a pre-determined deliverable or future outcome. Any contingent revenue for these arrangements is not recognized until the contingency is resolved and collectability is reasonably assured.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our arrangements with clients may include terms to deliver multiple services or deliverables. These contracts specifically identify the services to be provided with the corresponding deliverable. The value for each deliverable is determined based on the prices charged when each element is sold separately or by other vendor-specific objective evidence (“VSOE”) or estimates of stand-alone selling prices. Revenues are recognized in accordance with our accounting policies for the elements as described above (see Product Sales). The elements qualify for separation when the deliverables have value on a stand-alone basis, and the value of the separate elements can be established by VSOE or an estimated selling price.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While assigning values and identifying separate elements requires judgment, selling prices of the separate elements are generally readily identifiable as fixed and determinable as we also sell those elements individually outside of a multiple services engagement. Contracts with multiple elements typically incorporate a fixed-fee or hourly pricing structure. Arrangements are typically terminable by either party upon sufficient notice or do not include provisions for refunds relating to services provided.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reimbursable expenses, including those relating to travel, other out-of-pocket expenses, and any third-party costs, are included as a component of revenues. Typically, an equivalent amount of reimbursable expenses is included in total direct client service costs. Reimbursable expenses related to time and materials and fixed-fee engagements are recognized as revenue in the period in which the expense is incurred, and collectability is reasonably assured. Taxes collected from customers and remitted to governmental authorities are recognized as liabilities and paid to the appropriate government entities.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	us-gaap	Revenue Recognition Sales Of Goods RevenueRecognitionSalesOfGoods	<p id="xdx_84E_eus-gaap--RevenueRecognitionSalesOfGoods_zKwRwAbi1D4a" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_865_z5BkTfNqJT6l">Cannabis Sales</span></i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues consist of the retail sale of cannabis and related products. Revenue is recognized at the point of sale for retail customers. Payment is typically due upon transferring the goods to the customer or within a specified time period permitted under the Company’s credit policy. Sales discounts were not material during the three months ended March 31, 2024.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	us-gaap	Revenue Recognition Loyalty Programs RevenueRecognitionLoyaltyPrograms	<p id="xdx_84A_eus-gaap--RevenueRecognitionLoyaltyPrograms_zASx7Bj9oq27" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_868_zpED9ykjx5ij">Loyalty Reward Program</span></i></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company offers a loyalty reward program to its dispensary customers that provides a discount on purchases based on the total amount at the time of purchase. Management has determined that there is no separate performance obligation to the reward program, i.e., the accumulation and redemption of points, and as such, the Company recognizes the revenue at the time of purchase.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	us-gaap	Other Selling And Marketing Expense OtherSellingAndMarketingExpense	2448	usd
CY2023Q1	us-gaap	Other Selling And Marketing Expense OtherSellingAndMarketingExpense	30991	usd
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	9086	usd
CY2024Q1	us-gaap	Accounts Receivable Gross AccountsReceivableGross	124800	usd
CY2023Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	234330	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	4071	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	4071	usd
CY2024Q1	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	120730	usd
CY2023Q4	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	230259	usd
CY2024Q1	us-gaap	Interest And Debt Expense InterestAndDebtExpense	0	usd
CY2023Q1	us-gaap	Interest And Debt Expense InterestAndDebtExpense	0	usd
CY2023Q4	us-gaap	Advances To Affiliate AdvancesToAffiliate	162414	usd
CY2022Q4	us-gaap	Advances To Affiliate AdvancesToAffiliate	280705	usd
CY2024Q1	us-gaap	Proceeds From Deposits From Customers ProceedsFromDepositsFromCustomers	0	usd
CY2023	us-gaap	Proceeds From Deposits From Customers ProceedsFromDepositsFromCustomers	659790	usd
CY2024Q1	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	112922	usd
CY2023	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	778801	usd
CY2024Q1	us-gaap	Advances To Affiliate AdvancesToAffiliate	49492	usd
CY2023Q4	us-gaap	Advances To Affiliate AdvancesToAffiliate	162414	usd
CY2024Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	0	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	75300	usd
CY2024Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	626729	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	444532	usd
CY2024Q1	ammj	Finished Goods Soil FinishedGoodsSoil	0	usd
CY2023Q4	ammj	Finished Goods Soil FinishedGoodsSoil	0	usd
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	43197	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	66374	usd
CY2024Q1	us-gaap	Inventory Noncurrent InventoryNoncurrent	669926	usd
CY2023Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	586206	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	587448	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	580422	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	183881	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	170099	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	403567	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	410344	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1460000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-486888	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	973112	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1478464	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-440555	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1037909	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P11Y5M19D
CY2024Q1	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	0	usd
CY2023Q1	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	0	usd
CY2024Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	60115	usd
CY2023Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	46333	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths	186000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Two FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo	186000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Four FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour	186000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	145997	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive	54000	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	757997	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	142693	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	135213	usd
CY2024Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	26649	usd
CY2023Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	11711	usd
CY2024Q1	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	18289	usd
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	8319	usd
CY2024Q1	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	318752	usd
CY2023Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	312252	usd
CY2024Q1	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	506383	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	467495	usd
CY2024Q1	us-gaap	Loans Payable LoansPayable	17021	usd
CY2024Q1	us-gaap	Other Loans Payable OtherLoansPayable	17021	usd
CY2024Q1	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.125	pure
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	428229	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	428229	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	428229	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	208464	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	219765	usd
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	2017125	shares
CY2024Q1	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	4319628	shares
CY2024Q1	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	5000000	shares
CY2024Q1	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	3061224	shares

Files In Submission

Name	View Source	Status
0001903596-24-000418-index-headers.html	Edgar Link	pending
0001903596-24-000418-index.html	Edgar Link	pending
0001903596-24-000418.txt	Edgar Link	pending
0001903596-24-000418-xbrl.zip	Edgar Link	pending
ammj-20240331.xsd	Edgar Link	pending
ammj_10q.htm	Edgar Link	pending
ex31_1.htm	Edgar Link	pending
ex32_1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
ammj-20240331_def.xml	Edgar Link	unprocessable
ammj-20240331_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ammj_10q_htm.xml	Edgar Link	completed
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ammj-20240331_cal.xml	Edgar Link	unprocessable
ammj-20240331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AMMJ
American Cannabis Company, Inc. Stock $ammj

2024 Q3 Form 10-Q Financial Statement

#000190359624000418 Filed on July 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMMJ American Cannabis Company, Inc. Stock $ammj

2024 Q3 Form 10-Q Financial Statement

#000190359624000418 Filed on July 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMMJ
American Cannabis Company, Inc. Stock $ammj